Also trades as: 4565.T (JPX) · $vol 7M

$7.82

+0.00 (+0.00%)

OTC · Healthcare · Biotechnology · Tech Score Buy · Power 69 · $716.9M mcap · 74M float · 0.0006% daily turnover · Short 87% of daily vol

Revenue

$29.6B +2.8% ▲

5Y CAGR: +27.4%

Gross Profit

$21.4B +1.0% ▲

5Y CAGR: +21.5%

Operating Income

-$8.3B -52.7% ▼

Net Income

-$12.5B -159.2% ▼

EPS (Diluted)

$-139.60 -158.8% ▼

EBITDA

-$3.9B -3825.2% ▼

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$17.7B	$15.6B	$12.8B	$28.8B	$29.6B
YoY Growth	+100.3%	-12.1%	-18.0%	+125.9%	+2.8%
Cost of Revenue	$933M	$926M	$3.1B	$7.6B	$8.2B
Gross Profit	$16.8B	$14.6B	$9.7B	$21.2B	$21.4B
Gross Margin	94.7%	94.1%	75.7%	73.6%	72.3%
R&D Expenses	$5.9B	$7.5B	$10.1B	$11.8B	$14.5B
SG&A Expenses	$3.9B	$4.4B	$10.0B	$16.0B	$15.2B
Operating Expenses	$13.0B	$11.2B	$19.2B	$26.6B	$29.7B
Operating Income	$3.8B	$3.4B	-$9.5B	-$5.4B	-$8.3B
Operating Margin	21.3%	22.1%	-74.6%	-18.8%	-27.9%
Interest Expense	$3.8B	$756M	$2.5B	$783M	$7.5B
Income Before Tax	$433M	$1.1B	-$10.7B	-$4.7B	-$15.0B
Tax Expense	-$584M	$696M	-$3.5B	$176M	-$2.4B
Net Income	$1.0B	$382M	-$7.2B	-$4.8B	-$12.5B
Net Margin	5.7%	2.5%	-56.3%	-16.8%	-42.3%
EPS (Diluted)	$12.40	$4.63	$-87.17	$-53.95	$-139.60
EBITDA	$8.2B	$3.2B	-$5.7B	$105M	-$3.9B
Shares Outstanding	82M	83M	83M	90M	90M

Line Item	FY2024 Q3	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2
Revenue	$9.3B	$6.9B	$6.6B	$8.4B	$6.9B	$7.8B	$11.3B	$7.6B
Cost of Revenue	$2.0B	$2.1B	$1.6B	$1.9B	$2.7B	$2.1B	$1.1B	$2.1B
Gross Profit	$7.3B	$4.7B	$5.0B	$6.6B	$4.1B	$5.7B	$10.2B	$5.5B
Gross Margin	78.4%	69.0%	75.7%	78.0%	60.4%	73.6%	90.1%	71.7%
R&D Expenses	$3.0B	$3.3B	$3.8B	$3.7B	$3.8B	$3.3B	$3.0B	$3.0B
SG&A Expenses	$3.7B	$1.2B	$3.7B	$3.9B	$3.9B	$3.8B	$3.6B	$3.4B
Operating Expenses	$6.5B	$8.5B	$7.2B	$7.8B	$7.7B	$7.1B	$6.6B	$6.3B
Operating Income	$808M	-$3.8B	-$2.2B	-$1.2B	-$3.5B	-$1.4B	$3.6B	-$858M
Operating Margin	8.7%	-55.0%	-33.0%	-14.5%	-51.7%	-17.6%	31.4%	-11.3%
Interest Expense	$0	$0	$0	$1.0B	$207M	$5.8B	$289M	$481M
Income Before Tax	$865M	-$2.4B	-$2.2B	-$1.6B	-$3.2B	-$8.1B	$3.1B	-$1.6B
Tax Expense	$335M	$1.0B	$1.4B	$811M	-$1.5B	-$391M	$1.3B	-$1.4B
Net Income	$1.2B	-$1.3B	-$760M	-$2.4B	-$1.7B	-$7.7B	$1.8B	-$201M
Net Margin	13.0%	-19.5%	-11.4%	-28.1%	-24.8%	-99.4%	15.9%	-2.6%
EPS (Diluted)	$13.35	$-14.86	$-8.45	$-26.35	$-18.01	$-86.27	$17.58	$-2.20
EBITDA	$1.8B	-$2.8B	-$1.1B	$532M	-$1.8B	-$283M	$4.7B	$229M
Shares Outstanding	90M	90M	90M	90M	90M	90M	105M	91M

SOLTF OTC